Marinus Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of MRNS for the last quarter is 7.19 M USD, and it's 2.02% lower compared to the previous quarter. The net income of Q4 23 is -41.77 M USD.